DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/2ba823/generics_global_i) has
announced the addition of the "Generics: Global Industry Guide" report to their
offering.
"Generics: Global Industry Guide" is an essential resource for top-level data
and analysis covering the Generics industry. It includes detailed data on market
size and segmentation, textual analysis of the key trends and competitive
landscape, and profiles of the leading companies. This incisive report provides
expert analysis on a global, regional and country basis.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape
and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and
scorecards
* Covers the Global, European and Asia-Pacific markets as well as individual
chapters on 5 major markets (France, Germany, Japan, the UK and the US).
* Includes a five-year forecast of the industry
Highlights
The global generics market grew by 3.1% in 2008 to reach a value of $191.8
billion.
In 2013, the global generics market is forecast to have a value of $292 billion,
an increase of 52.2% since 2008.
Sales of ethical drugs proved the most lucrative for the global generics market
in 2008, generating 80.9% of the market's overall revenue.
Americas leads the global generics market accounting for 59.7% of the market's
revenue.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The generics market consists of all sales of generic drugs for human use at
ex-manufacturer prices. Datamonitor defines a generic as an officially-approved
copy of an original product whose patent has expired, marketed either as a brand
or using the generic name.
This definition excludes multi-source copy products that make up much of markets
such as India, Spain and Italy. Multi-source copies are drugs still under patent
that are offered by manufacturers other than the patent holders.
Key Topics Covered:
* CHAPTER 1 INTRODUCTION
* CHAPTER 2 GLOBAL GENERICS
* CHAPTER 3 GENERICS IN ASIA-PACIFIC
* CHAPTER 4 GENERICS IN EUROPE
* CHAPTER 5 GENERICS IN BELGIUM
* CHAPTER 6 GENERICS IN CANADA
* CHAPTER 7 GENERICS IN CHINA
* CHAPTER 8 GENERICS IN FRANCE
* CHAPTER 9 GENERICS IN GERMANY
* CHAPTER 10 GENERICS IN ITALY
* CHAPTER 11 GENERICS IN JAPAN
* CHAPTER 12 GENERICS IN THE NETHERLANDS
* CHAPTER 13 GENERICS IN SPAIN
* CHAPTER 14 GENERICS IN THE UNITED KINGDOM
* CHAPTER 15 GENERICS IN THE UNITED STATES
* CHAPTER 16 COMPANY PROFILES
* CHAPTER 17 APPENDIX
* LIST OF TABLES
* LIST OF FIGURES
For more information visit
http://www.researchandmarkets.com/research/2ba823/generics_global_i
Source: Datamonitor
Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Copyright Business Wire 2009
